Ab Initio Pharmaceuticals

Ab Initio Pharmaceuticals is a Sydney-based contract development and manufacturing organization (CDMO) that specializes in the formulation and production of complex pharmaceutical products. Operating out of the University of Sydney's Charles Perkins Centre, the company offers a comprehensive suite of services ranging from pre-formulation R&D to GMP-certified manufacturing for Phase I and II clinical trials. Their core expertise lies in advanced delivery technologies, particularly for inhalation, nasal, and high-potency oral dosage forms. Ab Initio serves as a critical bridge for biotech companies, providing the technical infrastructure and regulatory expertise needed to transition bench-top discoveries into clinical-grade candidates.